Diese Website verwendet Cookies, um das Angebot nutzerfreundlicher und effektiver zu machen. Mit der Nutzung dieser Website stimmen Sie der Verwendung von Cookies zu.Weitere Informationen über die Verwendung von Cookies und die Möglichkeit der Verwendung von Cookies zu widersprechen, finden Sie hier.
Deeply nourishing and regenerative oil serum with premium CBD, which protects the skin from free radical damage, visibly smooths fine lines and wrinkles, significantly increases elasticity and plumps facial contours.
Premium quality CBD is combined with a potent synergy of precious cold pressed oils such as Jojoba, Apricot kernel, Rosehip and Cranberry oil and enhanced with powerful plant extracts - Gotu Kola and premium quality essential oils Geranium, Bergamot, Rose and Palmarosa.
This unique, skin-loving serum will work to reduce the signs of aging with powerful regenerative, hydrating, restoring and harmonising properties.
It leaves the skin perfectly nourished, soft and smooth.
* This cosmetic product is perfectly safe, non-psychoactive and free from THC, GMOs, synthetic ingredients, parabens, phthalates, formaldehyde, artificial coloring. Vegan. Never tested on animals. Natural, skin-loving ingredients only.
Leider gibt es für diesen Aussteller kein deutsches Firmenprofil.
Myristica Ltd. is a Croatian company specialised in production, development and distribution of innovative healthcare products under the brand name 365 Nature.
Within the 365 Nature brand are unique wellness beauty products which combine premium CBD extract, precious herbal cold-pressed oils and therapeutic grade essential oils. Myristica’s brand 365 Nature also includes superb organic herbal tinctures and state-of-the-art food supplements based on natural ingredients as well as different dietary foods.
Myristica was established in 2008 and is continually developing innovative new health products.
Since, February 1st, 2019, 365 Nature Ltd. has been registered in London, U.K. for the purpose of selling and distributing the brand 365 Nature within the U.K. and other potential European markets.